Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Acquired_by_Fresenius_Kabi_in_2016
|
| gptkbp:awards |
Various industry awards
|
| gptkbp:clinicalTrials |
Conducts clinical trials
Conducts clinical research |
| gptkbp:collaborations |
Collaborates with universities
|
| gptkbp:community_engagement |
Yes
|
| gptkbp:customerBase |
Hospitals
Pharmacies Healthcare_providers |
| gptkbp:customerService |
Yes
|
| gptkbp:employees |
Over 1,000
|
| gptkbp:financialPerformance |
Publicly traded
|
| gptkbp:focus |
Specialty pharmaceuticals
Generic_pharmaceuticals |
| gptkbp:founded |
2000
|
| gptkbp:founder |
Vijay_K._S._K._Reddy
|
| gptkbp:headquarters |
Ahmedabad,_India
|
| https://www.w3.org/2000/01/rdf-schema#label |
Claris Lifesciences
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:investmentFocus |
Invests in R&D
|
| gptkbp:market |
Global
Expanding international presence Strong_market_presence_in_India |
| gptkbp:mission |
To improve patient outcomes
|
| gptkbp:partnerships |
Various global healthcare companies
|
| gptkbp:patentCitation |
Holds multiple patents
|
| gptkbp:productionLocation |
Multiple_facilities_in_India
|
| gptkbp:productLine |
Diverse product pipeline
|
| gptkbp:products |
Injectable drugs
Infusion solutions |
| gptkbp:regulatoryCompliance |
gptkb:FDA
EMA WHO |
| gptkbp:research_areas |
Oncology
Pain management Anesthesia Infectious diseases Critical care |
| gptkbp:researchAndDevelopment |
Yes
|
| gptkbp:services |
Contract manufacturing
|
| gptkbp:stockExchange |
gptkb:CLARIS
|
| gptkbp:subsidiary |
gptkb:Claris_Life_Sciences_USA
gptkb:Claris_Lifesciences_Europe gptkb:Claris_Injectables gptkb:Claris_Lifesciences_Asia Claris_Lifesciences_Africa |
| gptkbp:supplyChain |
Global supply chain
|
| gptkbp:sustainability_initiatives |
Yes
|
| gptkbp:vision |
To be a global leader in pharmaceuticals.
|
| gptkbp:website |
www.clarislifesciences.com
|